Nature's BioCeuticals Denmark ApS: Financial statements 2022
CVR: 41912367
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
Nature's BioCeuticals Denmark ApS (CVR 41912367) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -943,913 and a net result of DKK -1,517,144. Equity in the 2022 report amounted to DKK -1,497,160.
- Gross Profit
- DKK -943,913
- Profit/Loss
- DKK -1,517,144
- Equity
- DKK -1,497,160
- Total Assets
- DKK 14,482,183
Official annual report
Keep an eye on Nature's BioCeuticals Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of August 26, 2022, Francois Jean-Martin Susini is registered as director of Nature's BioCeuticals Denmark ApS.
As of August 26, 2022, David Dean Krenbrink has stepped down as director of Nature's BioCeuticals Denmark ApS.
About Nature's BioCeuticals Denmark ApS
Nature's BioCeuticals Denmark ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Egehoj Development ApS. The management consists of Francois Jean Martin Susini. The company is owned by Green Vault Group. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -129,477 and a net result of DKK -611,024 compared with DKK -897,649 the year before. Equity in the 2025 report amounted to DKK 12,151,659.